In patients with paroxysmal atrial fibrillation (Paf), the identification of the coexistence of sinus node dysfunction (SND) has therapeutic implications. This study sought to prospectively determine whether SND in patients with Paf would be identified by use of atrial early potential (EP), low-amplitude potentials early in signal-averaged P wave.
abnormalities in the perinodal atrial muscle, would be characteristic of SND. 16 Therefore the purpose of this study was to prospectively determine whether the involvement of SND in patients with Paf would be identified by EP.
Methods

Study patients
One hundred fifty-six consecutive patients with Paf, who underwent P-wave signal-averaged electrocardiography between January 1995 and December 1998 in Osaka Prefectural General Hospital, were screened for this study. One hundred eighteen of 156 study patients were admitted because of the examination results and for treatment of arrhythmias in 51 patients, heart catheterization in 37 patients, and the management of diseases other than heart disorder (diabetes mellitus, brain infarction, etc) in 30 patients, whereas the remaining 38 patients were in the outpatient clinical setting. Paf was defined as an arrhythmia of supraventricular origin associated with a grossly irregular ventricular rhythm and no visible P or flutter waves that lasted for >1 minute and did not persist for 6 months. Seven patients were excluded because (1) 6 patients were taking antiarrhythmic agents that could affect the results of P-wave signal-averaged electrocardiography, and (2) the mean noise level was >1 µV in the composite lead of P-wave signal-averaged electrocardiogram in the remaining 1 patient. A total of 149 patients were enrolled in this study. Each patient gave informed consent to participate in this study, which was Some patients with paroxysmal atrial fibrillation (Paf) have the coexistence of sinus node dysfunction (SND). [1] [2] [3] [4] In cases in which the preventive antiarrhythmic drugs for Paf were administered to these patients with occult SND, the termination of Paf might be followed by unpredictable longer pauses, leading to presyncope or syncope. Thus the identification of the coexistence of SND in patients with Paf has therapeutic implications.
We [5] [6] [7] [8] and other investigators [9] [10] [11] reported that the electrophysiological abnormalities of the atrial muscle in patients with Paf could be detected noninvasively by Pwave signal-averaged electrocardiography. In the pathologic studies of SND, a lesion such as degeneration and fibrosis has been shown not only in the sinus node but also in the perinodal atrial muscle. [12] [13] [14] [15] Recently, in a retrospective study, we reported that low-amplitude potentials early in the signal-averaged P wave, atrial early potentials (EP), which might reflect the conduction approved by the Osaka Prefectural General Hospital Review Committee.
The mean age of 149 patients was 61 ± 14 years. There were 97 men and 52 women. Eighty-six patients had no organic heart disease, and the remaining 63 patients had organic heart diseases or another disease that possibly caused Paf (24 patients with ischemic heart disease, 14 with pericardial or myocardial diseases, 11 with valvular heart disease, 9 with hypertension or hypertensive heart disease, 4 with congenital heart disease, and 1 with pulmonary embolism). One hundred forty of 149 patients had symptomatic episodes. Seventy-seven patients experienced only palpitation, and the remaining 63 patients had other symptoms besides palpitation. Eighteen patients had syncope, 15 presyncope, 5 lightheadedness, 17 exertional dyspnea, 7 chest pain, and 1 easy fatigability. The interval from the first symptomatic episode, such as palpitation, to entry, defined as the time of P-wave signal-averaged electrocardiogram, was 26 ± 49 months, and the interval from the last symptomatic episode to entry was 1.2 ± 0.8 months in patients with symptomatic Paf attacks.
As a control group, we also studied 15 patients with SND without Paf in our previous prospective study. 17 The mean age of 15 patients was 66 ± 15 years. There were 8 men and 7 women. Ten patients had no organic heart disease, and the remaining 5 patients had organic heart disease (2 patients with ischemic heart disease, 2 with hypertension or hypertensive heart disease, and 1 with chronic myocarditis). Thirteen of 15 patients had symptomatic episodes. Six patients experienced syncope, 3 had presyncope, 2 had light-headedness, 1 had chest pain, and 1 had palpitation. The sinus pause documented by Holter monitoring was 5.3 ± 2.5 seconds.
P-wave signal-averaged electrocardiography
In all patients, P-wave signal-averaged electrocardiography was performed at the entry in a blinded fashion to the patients' clinical data. The method of P-wave signal-averaged electrocardiographic recording and analysis has been described previously. [5] [6] [7] 16, 18 No patients in this study had received antiarrhythmic drugs for at least 1 week before undergoing P-wave signal-averaged electrocardiography. They had never received amiodarone before the entry. Eight patients received digitalis, and 9 patients received calcium antagonist at the recording of P-wave signal-averaged electrocardiography. In an electrically shielded room, which minimized noise, P-wave signal-averaged electrocardiography was recorded from a modified X-, Y-, and Z-lead system by use of the VCM-3000 (Fukuda Denshi, Ltd, Tokyo, Japan), which was recently developed for P-wave-triggered signal averaging. The X lead was between the right and left shoulders (standard lead I). The aV F lead was used as the Y lead. The precordial V 1 lead was used as the Z lead. The signal from each lead was amplified up to 5 µV/cm and passed through a unidirectional Butterworth filter of 40 Hz (the slope; 18 decibels per octave [dB/oct]) to 300 Hz (the slope; 12 dB/oct) and was then converted from analog to digital data to a 12-bit accuracy at a sampling rate of 1 kHz.
A specially filtered P wave derived from the selected dominant sinus P wave of the standard II lead served as a reference signal (template) for all processing. The specially filtered P wave was obtained with a band-pass filter of 10 to 30 Hz for making the P wave spiky as a trigger signal. After passing through a P-wave recognition program to eliminate ectopic atrial beats, the signals of more than 200 beats were averaged on a trigger point within a specially filtered P wave. Noise levels were measured every 1 millisecond in the last 20 milliseconds of TP segment on the filtered lead of a vector magnitude, the square root of X 2 + Y 2 + Z 2 . Signal averaging was continued until the noise amplitude at all points in this interval was reduced to less than 1 µV (peak noise level). The root mean square noise value was 0.3 ± 0.2 µV.
The signals for the X, Y, and Z leads were combined into the vector magnitude. The signal-averaged P wave in the vector magnitude was defined as signal within the interval showing a persistent level >1 µV. The onset and offset of signal-averaged P waves were manually determined without knowledge of the patient's clinical data. We measured the root mean square voltages for the initial 30 milliseconds of signal-averaged P wave (EP30) and the shortest duration from the onset up to 4 µV of signal-averaged P wave (ED4). In our previous study, 16 the criteria of atrial early potentials (EP) had been defined as EP30 <3.0 µV and ED4 >22 MS. Furthermore, the duration and the root mean square voltage for the last 20 MS of signal-averaged P wave were also measured.
Diagnosis of the presence of SND
SND was diagnosed by use of conventional 12-lead electrocardiography, 24-hour ambulatory Holter monitoring, bedside monitoring with continuous electrocardiographic telemetry, or electrophysiologic study, which were performed within 1 month after P-wave signal-averaged electrocardiography was recorded. All of the 149 patients underwent 24-hour Holter monitoring or bedside electrocardiographic monitoring. In 136 of 149 patients, 24-hour ambulatory Holter electrocardiography was recorded and was analyzed by use of a Marquette Electronics 8000 Holter monitoring system (Marquette Electronics, Milwaukee, Wis). In 118 of 149 patients, bedside monitoring with continuous electrocardiographic telemetry was also performed for at least 2 days (5 ± 3 days). Patients were considered to have SND if they had an episode of sinus arrest or sinoatrial block (with a pause >2 seconds), persistent and unexplained sinus bradycardia (<40 beats/min), prolonged corrected sinus recovery time (CSRT >600 milliseconds), or sinoatrial conduction time (SACT >150 milliseconds). 4, [16] [17] [18] [19] Electrophysiologic study
We performed electrophysiologic study within several days of the recording of P-wave signal-averaged electrocardiography in 40 patients for the further examination of sinus node function in 21 patients and coexistence of arrhythmias other than SND in 19 patients (ventricular tachycardia in 8, atrioventricular tachycardia in 4, atrioventricular nodal reentrant tachycardia in 3, paroxysmal atrial flutter in 2, intraatrial reentrant tachycardia in 1, and ventricular fibrillation in 1 patient). As described in our previous study, 16 high right atrial electrograms were recorded through a band pass filter of 30 to 500 Hz, and atrial stimulation was performed by use a programmable stimulator (Nihon Koden, Ltd, Tokyo, Japan) used at twice-diastolic threshold and 2 MS in duration. SACT was obtained according to Narula's method. 20 Furthermore, CSRT was obtained by overdriving method (pacing high right atrium for a 30-second period at 80 to 180 beats/min). 21 
Echocardiographic measurement
Echocardiography was performed by a Toshiba SSH-160A recorder equipped with 2.5-to 3.5-MHz transducers in 135 of 149 patients at the entry. The standard technique 22 was used for sizing the left ventricle and atrium. Left ventricular enddiastolic and end-systolic dimensions and left atrial dimension were measured, and the left ventricular ejection fraction was calculated by Gibson's method.
Statistical analysis
Data are presented as mean ± SD. The Student t test and a Fisher exact test were used to compare differences of continuous and discrete variables, respectively, in patients with Paf with and without EP. These analyses were also used for the comparison between patients with Paf with and without SND and the comparison between patients with SND with and without Paf. The statistical significance was detected at P < .05.
Results
Clinical characteristics in patients with Paf with and without EP
Thirty-eight (26%) of 149 patients with Paf had EP. Figure 1 shows the representative tracings of P-wave signal-averaged electrocardiograms in patients with Paf with and without EP. Of note, the initial portion of the signal-averaged P wave is lower in amplitude and longer in duration in patients with than without EP. Table I shows clinical characteristics in patients with Paf with and without EP. There were no significant differences in age, sex, the presence of organic heart disease, or resting heart rate between the two groups.
Study characteristics in patients with Paf with and without EP EP30 and ED4 were 2.02 ± 0.47 µV and 37.2 ± 14.7 milliseconds in patients with Paf with EP and 4.14 ± 1.44 µV and 12.8 ± 6.1 milliseconds in patients with Paf without EP, respectively. Table II shows study characteristics of patients with Paf with and without EP. There were no significant differences in the percentage of patients who underwent Holter monitoring (97% vs 89%) or bedside electrocardiography monitoring (84% vs 78%) or the period of the bedside monitoring (4.8 ± 3.0 vs 5.1 ± 3.0 days) between patients with Paf with and without EP. In Holter or bedside monitoring, sinus
Figure 1
Representative P-wave signal-averaged electrocardiograms in patients with Paf with and without atrial EP. Criteria of EP was defined as "EP30 < 3.0 µV and ED4 >22 milliseconds." Dotted lines indicate beginning and end of signal-averaged P wave. Note that initial portion of signal-averaged P wave is lower in amplitude and longer in duration in patient with Paf with than without EP.
arrest or sinoatrial block was significantly more frequently observed in patients with Paf with than without EP, although there was no significant difference in maximum pause time between the two groups. In electrophysiologic study, SACT and CSRT were significantly longer in patients with Paf with than without EP. Echocardiographically, there were no differences in the left ventricular end-diastolic dimension, ejection fraction, or left atrial dimension between the two groups.
Clinical characteristics in patients with Paf with SND Twenty-three of 149 patients with Paf were diagnosed as having SND. All but two patients with SND experienced symptoms related to the arrhythmia, in addition to palpitation. Seven patients experienced syncope, 7 had presyncope, 3 had light-headedness, 2 had chest pain, 1 had exertional dyspnea, and 1 had easy fatigability. The mean of maximum pause time was 5.1 ± 4.7 (2.2 to 9) seconds. The pause was documented at the termination of Paf in 13 patients and was also observed at the occurrence of sinoatrial block in 11 patients. Eleven (61%) of 18 patients with Paf with SND and EP experienced the pause because of sinoatrial block, whereas sinoatrial block was documented in none of 5 patients with Paf with SND but without EP. The pause documented at sinoatrial block was significantly more frequently observed in patients with Paf with SND and EP than those without EP (P < .05), whereas there was no significant difference in the maximum pause time between the patients with and without EP.
Identification of patients with Paf with SND by use of EP
Eighteen (47%) of 38 patients with EP had SND, whereas SND was found in only 5 (5%) of the other 111 patients without EP. EP had a sensitivity of 78%, a specificity of 84%, a positive predictive value of 47%, and a negative predictive value of 95% for the identification of SND in patients with Paf. Patients with Paf with EP had an increased likelihood of the involvement of SND (odds ratio 19.1; 95% confidence interval [CI] 6.4 to 57.3; P < .0001).
Comparison between patients with Paf with and without SND Table III shows the clinical and study characteristics of patients with Paf with and without SND. Although there were no significant differences in sex, resting heart rate, or the presence of organic heart disease between patients with Paf with and without SND, patients with SND were significantly older and had the episode of syncope or presyncope significantly more frequently than those without SND. In patients with Paf with SND, the 95% CIs of EP30 and ED4 were 1.90 to 2.63 µV and 28.2 to 45.4 milliseconds, respectively. In patients with Paf without SND, the 95% CI of EP30 and ED4 were 3.57 to 4.12 µV and 14.1 to 17.4 milliseconds, respectively. EP30 was significantly lower, and ED4 was longer in patients with than without SND (Figure 2 ).
Comparison between patients with SND with and without Paf
Table III also shows the clinical and study characteristics of patients with SND with and without Paf. There was significant difference in neither EP30 nor ED4 between SND patients with and without Paf (Figure 2) . The incidence of EP in patients with SND with 
Follow-up study
After the initial examination, all of the patients in this study were followed up for 18 ± 15 months. In 19 of 23 patients with Paf who had been diagnosed as having SND at the initial examination, permanent pacemakers were implanted according to American College of Cardiology/American Heart Association guidelines. 23 Two years after the recording of P-wave signal-averaged electrocardiography, SND was newly involved in one of 126 patients (20 with and 106 without EP) who had been diagnosed as having no coexistence of SND at the initial examination. One (5%) of 20 patients with EP had the involvement of SND, whereas SND coexisted in none of 106 patients without EP during the follow-up period.
Discussion
Signal-averaged electrocardiography had been developed to detect ventricular and atrial late potentials from the body surface and provided a useful approach to identify patients at risk for ventricular tachycardia [24] [25] [26] and paroxysmal atrial fibrillation. [5] [6] [7] [8] [9] [10] [11] Recently, we reported that patients with SND had long, low-amplitude signals in the initial portion of signal-averaged P wave. 16 However, the previous study was performed in a retrospective fashion. Therefore this prospective was done, which demonstrated that EP could be useful for identifying the involvement of SND in patients with Paf.
Pathophysiologic consideration about EP
Electrophysiological study with intraatrial catheter mapping of the right atrium showed that the area of diseased atrial muscle, where fractionated atrial electrograms were recorded, was more extensive in patients with both Paf and SND than that in patients with Paf alone. 3 Irrespective of the presence of Paf, patients with SND had the fractionated atrial electrograms mainly recorded in the high right atrium in the vicinity of the sinus node 27 and the widening of fragmented activity zone, compared with those with normal sinus node function. 19, 28 In the pathologic studies of SND, abnormalities such as degeneration and fibrosis have been shown not only in the sinus node but also in the atrial muscle, especially the perinodal portion. [12] [13] [14] [15] These findings show that some pathologic and electrophysiologic abnormalities in the atrial muscle besides the sinus node itself might be involved in SND.
In this study SACT was significantly prolonged in patients with than without EP. In our previous study, EP30 significantly inversely correlated and ED4 also significantly correlated with SACT. 16 Moreover, in this study the duration of atrial electrography at the high right atrium was significantly correlated with EP30 (r = 0.39, P = .03 [n = 30]) and ED4 (r = 0.55, P = .002). We believe that EP might reflect the conduction abnormalities in the perinodal sinoatrial conducting cells or perinodal atrial muscle. In SND the conduction of excitation from sinus node through perinodal Ad, The duration of signal-averaged P wave; LP20, the root mean square voltage for the last 20 milliseconds of the signal-averaged P wave. *P < .05 vs Paf without SND. †P < .001 vs Paf without SND. [12] [13] [14] [15] which might make the amplitude and duration in the initial portion of signal-averaged P wave lower and longer. Patients with both Paf and SND often show the substantial pause documented not only at the termination of Paf attacks but also at the occurrence of sinoatrial block. In this study the pause resulting from sinoatrial block was significantly more frequently observed in patients with SND with than without EP. This finding also suggests that EP might reflect the conduction abnormalities of the excitation from sinus node through perinodal atrial tissue.
Clinical implication of EP
In this study some patients with Paf had coexisting SND. If the preventive antiarrhythmic drugs for Paf are administered to these patients with occult SND, the termination of Paf might be followed by unpredictable longer pauses leading to presyncope or syncope. The presence of EP in patients with Paf might suggest sinoatrial or atrial conducting disease as the underlying problem. Before the preventive antiarrhythmic drugs are administered to patients with Paf and EP, we should investigate whether SND might be involved in these patients. Thus the identification of coexistence of SND in patients with Paf by use of EP would have therapeutic implication.
In this study permanent pacemakers for SND were implanted in 19 of 149 patients with Paf. EP30 was significantly lower (2.10 ± 1.08 vs 3.82 ± 1.54 µV; P < .0001), and ED4 was significantly longer (40.8 ± 19.7 vs 16.0 ± 9.7 milliseconds, P < .0001) in patients with Paf with than without pacemaker implantation. Eighteen (47%) of 38 patients with Paf and EP had undergone the implantation of pacemaker, whereas a pacemaker was implanted in only 3 (3%) of 111 patients with Paf but without EP. EP gave a sensitivity of 84% and a specificity of 75% for the identification of patients with Paf with pacemaker implantation for coexistent SND. These results suggest that EP would also be a marker to identify patients with Paf with the requirement of pacemaker implantation for SND.
In patients diagnosed with syncope, it is clinically important to rapidly clarify the cause. We previously reported that EP would be also useful for the identification of SND in patients with syncope. 18 In this study, 18 of 149 patients with Paf experienced syncope, and EP was observed in 6 of the 18 patients with Paf with syncope. All (100%) of the 6 patients with Paf with syncope and EP had SND, whereas SND was found in only 1 (8%) of the other 12 patients with Paf with syncope without EP (P = .001; sensitivity 87%, specificity 100%). This result also indicates that EP could be a rapid and accurate marker to identify the involvement of SND in patients with Paf and syncope.
Identification of SND in patients with Paf by the combination of EP and the episode of syncope or presyncope
In this study SND was significantly more frequently found in patients with Paf with than without the epi- [13/138] ; odds ratio 96.1; 95% CI 11.3 to 812; P < .0001). In other words, the likelihood of the involvement of SND was increased 96-fold if the patients with Paf with EP had the episode of syncope or presyncope. Thus the combination of EP and the episode of syncope or presyncope would identify the highest risk subset of patients with Paf with SND.
Limitations of this study
In this study we carefully examined the involvement of SND by conventional electrocardiography, bedside monitoring, or 24-hour Holter monitoring. However, it cannot be ruled out that some cases of SND may remain undocumented, because there are variations in the result of the electrocardiographic monitorings. Furthermore, the rate of invasive evaluation for SND was low (27%), because the acceptance of electrophysiological study as a diagnostic tool in patients with SND remains limited. 4 However, in this study, SND was significantly more frequently found in patients with EP (n = 17) than in those without EP (n = 23) who underwent electrophysiologic study (82% vs 23%; P = .0003). SND was also significantly more frequently found in patients with EP (n = 21) than those without EP (n = 89) who did not undergo electrophysiologic study (19% vs 0%; P = .001).
In this study, the low amplitude of the initial portion of the signal-averaged P wave was not always found in all patients with sick sinus syndrome. SND with prolonged CSRT without prolonged SACT was significantly more frequently observed in patients without than with EP (80% vs 11%; P < .01). The initial low-amplitude signals might be lacking in patients whose disease is purely limited to depressed automaticity of sinus node without sinoatrial conduction disease or atrial disease.
Conclusion
This study revealed that EP on P-wave signal-averaged electrocardiography would be useful for the identification of the involvement of SND in not only patients with Paf but also patients without Paf, indicating that EP would be specific to SND.
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